Orthostatic Hypotension: Next Step When Midodrine Has Not Achieved Blood Pressure Targets
When midodrine, added to first-line measures, has failed to adequately raise blood pressure or resolve orthostatic symptoms, a further escalation is warranted. This page describes that clinical scenario and points to the full structured protocol.
Previous Treatment — Insufficient Response
Midodrine (alpha-agonist), used as an add-on to first-line treatment, did not achieve the required therapeutic goals: a sufficient increase in blood pressure in both the supine and upright posture, and meaningful amelioration of orthostatic symptoms. Escalation to the next treatment line is clinically indicated.
Clinical Goals at This Stage
Reduced orthostatic symptoms together with a measurable increase in blood pressure.
Next-Line Approach — Partial Overview
At this stage, a mineralocorticoid agent is introduced to address the persistent haemodynamic deficit.
Complete regimen, sequencing, and monitoring detail are available in the full protocol.
References
DOI: 10.1093/eurheartj/ehy037
Fludrocortisone should be considered if symptoms persist.
The evidence in favour of fludrocortisone is from two small observational studies (in combination with head-up sleeping) and one double-blind trial in 60 patients; the observational studies showed haemodynamic benefit and, in the trial, treated patients were less symptomatic with higher BP.
View source ↗